CEO David Hallal sold $192K of Alexion Pharmaceuticals, Inc.

Sold$192,132

$135.88Price

1,414Shares

−1%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Fri, Apr 1. Filed Tue, Apr 5, 5:26 PM ET, after the close. Not investment advice.